Filamin A (FLNA) modulates chemosensitivity to docetaxel in triple-negative breast cancer through the MAPK/ERK pathway
Crossref DOI link: https://doi.org/10.1007/s13277-015-4357-3
Published Online: 2015-11-07
Published Print: 2016-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Zhao, Pengxin
Ma, Weiyuan
Hu, Zhigang
Zang, Leilei
Tian, Zhisheng
Zhang, Kaili
Funding for this research was provided by:
Hebei Medical Development Funding (HMDF-KJJ)
Text and Data Mining valid from 2015-11-07